BDBM298037 3-{5-[4-methyl-2-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl}-7-(piperidin-4-yl)pyrazolo[1,5-c]pyrimidin-5(4H)-one hydrochloride::US10118930, Example 249

SMILES Cc1ccc(-c2nc(-c3cnn4c(C5CCNCC5)cc(=O)[nH]c34)no2)c(C(F)(F)F)c1

InChI Key InChIKey=CEBYMMAYEXZHDX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 298037   

TargetTissue-type plasminogen activator(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 298037BDBM298037(US10118930, Example 249 | 3-{5-[4-methyl-2-(triflu...)
Affinity DataIC50: 12nMAssay Description:The clot-lysis test system configures the kinetics of clot formation and degradation in vitro and allows quantifying modulation of the process by sel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent